GYNEMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GYNEMED
Largest movements
- Cash +€11,427
up €11,427 (+673.6%), from €1,696 to €13,124
mainly Other debts (+€17,308) and Deferred charges and accrued income (+€2,809)
- Deferred charges and accrued income -€2,809
down €2,809 (-89.5%), from €3,140 to €331
- Other debts +€17,308
up €17,308 (+101.1%), from €17,127 to €34,435
- Profit (loss) carried forward -€4,848
down €4,848 (-8.9%), from -€54,566 to -€59,414
- Trade debts -€3,842
down €3,842 (-79.4%), from €4,840 to €998
- Other operating charges +€1,134
up €1,134 (+130.5%), from €869 to €2,003
- Purchases and services -€1,112
down €1,112 (-16.1%), from €6,902 to €5,791
- Turnover +€1,002
new in 2025: €1,002
- Gross operating margin +€987
up €987 (+26.2%), from -€3,762 to -€2,776
- Financial charges -€149
down €149 (-63.8%), from €233 to €84
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,836 | €13,455 | +€8,618 | +178.2% |
| Fixed assets | 21/28 | €0 | €0 | = | |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €0 | €0 | = | |
| Furniture and vehicles | 24 | €0 | €0 | = | |
| Current assets | 29/58 | €4,836 | €13,455 | +€8,618 | +178.2% |
| Amounts receivable within one year | 40/41 | €0 | - | = | |
| Trade receivables | 40 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €1,696 | €13,124 | +€11,427 | +673.6% |
| Deferred charges and accrued income | 490/1 | €3,140 | €331 | -€2,809 | -89.5% |
| Total equity and liabilities | 10/49 | €4,836 | €13,455 | +€8,618 | +178.2% |
| Equity | 10/15 | -€17,130 | -€21,978 | -€4,848 | -28.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Capital | 10 | €18,600 | €18,600 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €18,836 | €18,836 | = | 0.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Legal reserve | 130 | €0 | - | = | |
| Distributable reserves | 133 | €18,836 | €18,836 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€54,566 | -€59,414 | -€4,848 | -8.9% |
| Amounts payable | 17/49 | €21,967 | €35,433 | +€13,466 | +61.3% |
| Amounts payable within one year | 42/48 | €21,967 | €35,433 | +€13,466 | +61.3% |
| Trade debts | 44 | €4,840 | €998 | -€3,842 | -79.4% |
| Suppliers | 440/4 | €4,840 | €998 | -€3,842 | -79.4% |
| Other amounts payable | 47/48 | €17,127 | €34,435 | +€17,308 | +101.1% |
| Turnover | 70 | - | €1,002 | +€1,002 | |
| Goods, raw materials, services and sundry goods | 60/61 | €6,902 | €5,791 | -€1,112 | -16.1% |
| Other operating charges | 640/8 | €869 | €2,003 | +€1,134 | +130.5% |
| Gross operating margin | 9900 | -€3,762 | -€2,776 | +€987 | +26.2% |
| Operating profit (loss) | 9901 | -€4,632 | -€4,779 | -€147 | -3.2% |
| Financial charges | 65/66B | €233 | €84 | -€149 | -63.8% |
| Recurring financial charges | 65 | €233 | €84 | -€149 | -63.8% |
| Profit (loss) for the period before taxes | 9903 | -€4,864 | -€4,863 | +€1 | 0.0% |
| Income taxes | 67/77 | - | -€15 | -€15 | |
| Profit (loss) for the period | 9904 | -€4,864 | -€4,848 | +€16 | +0.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€4,864 | -€4,848 | +€16 | +0.3% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.